Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission

PHASE4CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

May 31, 2020

Study Completion Date

May 31, 2020

Conditions
Crohn Disease
Interventions
DRUG

Infliximab

OTHER

Placebo

Trial Locations (13)

2400

Bispebjerg Hospital, Copenhagen

2730

Herlev Hospital, department of gastroenterology medical section, Herlev

4200

Slagelse Sygehus, Slagelse

4800

Nykøbing F. Sygehus, Nykøbing Falster

5000

Odense University hospital, Odense

8000

Aarhus University Hospital, Aarhus

Unknown

Hospital enheden vest Herning, Herning

Hvidovre Hospital, Hvidovre

Silkeborg Regional Hospital, Diagnostic Center, Silkeborg

Helsinki University Hospital and University of Helsinki, Helsinki

Akerhus University Hospital, Oslo

Skane University Hospital, Lund

Karolinska Institute, Stockholm

All Listed Sponsors
lead

Copenhagen University Hospital at Herlev

OTHER

NCT01817426 - Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission | Biotech Hunter | Biotech Hunter